BeStock  
Stocks › Biotechnology › ALMS

Alumis ALMS

US equityMarket cap rank #3330Biotechnology
$6.77 −$0.16 (-2.31%)
Pre-market · Oct 8, 9:10 am ET · After hours $6.77 0.00%
Open$6.82
Prev close$6.93
Day range$6.71 – $6.95
Volume2.17M
Market cap$876.28M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership92.3%-4.64 pts vs. prior quarter
Institutions holding238-3 vs. prior quarter
Insider trades (recent)41 buys / 9 sellsNet buying
Short interest4.87% of floatDays to cover 1.0 · as of 15 Sep 2026
Short-sale volume share18.5%5-day average of daily volume

Short-sale volume as % of daily volume

9%16%23%29%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$11.30M (3 inflow days, 17 outflow days).

Net flow by order size, last 20 sessions

−$4.0MSuper−$7.3MBig−$5.5MMid−$6.9MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 36.0% of shares outstanding.

Largest holders

  • Matrix Capital Management Company, LP11.70%
  • Foresite Capital Management, LLC7.09%
  • BlackRock6.35%
  • Samsara BioCapital LLC5.59%
  • FMR5.23%
  • Deep Track Capital, LP4.90%
  • T. Rowe Price Group, Inc.4.02%
  • Vanguard Capital Management, LLC3.73%

By investor type

  • Mutual Fund33.70%
  • VC/PE Fund30.01%
  • Hedge Fund26.27%
  • Public Company1.46%
  • Individual/Insider0.54%
  • Private Company0.42%
  • Government Pension Fund0.20%
  • Insurance Company0.17%

Reported short interest has fallen from 11.21% to 4.87% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Samsara BioCapital LLC VC/PE Fund 2026/Q3 +890,590 5.6%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +158,746 0.2%
FMR Mutual Fund 2026/Q3 +5,795,331 5.2%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,913,085 4.0%
Novo Holdings A/S VC/PE Fund 2026/Q3 +1,100,000 0.8%
BlackRock Mutual Fund 2026/Q3 +1,047,283 6.3%
Woodline Partners LP Hedge Fund 2026/Q3 +486,052 0.4%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +396,105 0.7%
State Street Global Advisors Mutual Fund 2026/Q3 +385,454 1.7%
Citigroup Inc. Public Company 2026/Q3 +286,476 0.3%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +268,142 3.7%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +250,102 1.7%
Janus Henderson Group plc Mutual Fund 2026/Q3 +230,714 1.8%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +208,603 0.7%
Trium Capital Managers Ltd Mutual Fund 2026/Q3 +198,877 0.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
7 Sep 2026 Samsara BioCapital LLC Open Market Disposition -96,131 $10.55 7,235,809
7 Sep 2026 Samsara BioCapital LLC Open Market Acquisition +986,721 $11.17 7,235,809
2 Aug 2026 Roy Hardiman Chief Business & Legal Officer Open Market Disposition -2,692 $26.37 195,496
2 Aug 2026 John Schroer Chief Financial Officer Open Market Disposition -3,282 $26.37 3,718
2 Aug 2026 David Goldstein Chief Scientific Officer & Head of CMC Open Market Disposition -2,596 $26.37 230,201
2 Aug 2026 Jorn Drappa Chief Medical Officer & Head of Research and Development Open Market Disposition -2,447 $26.37 39,925
2 Aug 2026 Sanam Pangali Chief Legal Officer Open Market Disposition -1,364 $26.37 3,080
2 Aug 2026 Mark Bradley Chief Development Officer Open Market Disposition -2,572 $26.37 70,752
5 Jul 2026 Sanam Pangali Chief Legal Officer Derivative Exercise and Sale -5,000 $28.00 1,111
29 Jun 2026 Srinivas Akkaraju Independent Director Other Acquisition +3,553 – 3,553
29 Jun 2026 Srinivas Akkaraju Independent Director Other Derivative Acquisition +15,528 $28.14 15,528
29 Jun 2026 Sapna Srivastava Independent Director Other Acquisition +3,553 – 3,553
29 Jun 2026 Sapna Srivastava Independent Director Other Derivative Acquisition +15,528 $28.14 15,528
29 Jun 2026 Lynn Tetrault Independent Director Other Acquisition +3,553 – 3,553
29 Jun 2026 Lynn Tetrault Independent Director Other Derivative Acquisition +15,528 $28.14 15,528
29 Jun 2026 C. Machado Independent Director Other Acquisition +3,553 – 3,553
29 Jun 2026 C. Machado Independent Director Other Derivative Acquisition +15,528 $28.14 15,528
29 Jun 2026 Zhengbin Yao Independent Director Other Acquisition +3,553 – 3,553
29 Jun 2026 Zhengbin Yao Independent Director Other Derivative Acquisition +15,528 $28.14 15,528
21 May 2026 Jorn Drappa Chief Medical Officer & Head of Research and Development Derivative Exercise and Retained +26,852 $8.84 33,889

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 6,299,106 4.9% 1.0
31 Aug 2026 5,645,753 4.4% 7.1
14 Aug 2026 5,853,901 4.5% 6.5
31 Jul 2026 5,766,070 4.5% 6.1
15 Jul 2026 6,764,417 5.3% 3.8
30 Jun 2026 14,294,503 11.2% 7.6

Discussion

No comments yet — be the first to weigh in on ALMS.

Leave a comment

Scroll to Top